114 related articles for article (PubMed ID: 25576930)
41. Mechanisms of nerve injury in leprosy.
Scollard DM; Truman RW; Ebenezer GJ
Clin Dermatol; 2015; 33(1):46-54. PubMed ID: 25432810
[TBL] [Abstract][Full Text] [Related]
42. Characterization of the anti-neural antibodies in the sera of leprosy patients.
Eustis-Turf EP; Benjamins JA; Lefford MJ
J Neuroimmunol; 1986 Feb; 10(4):313-30. PubMed ID: 3511085
[TBL] [Abstract][Full Text] [Related]
43. C-reactive protein and apoB containing lipoproteins are associated with Mycobacterium leprae in lesions of human leprosy.
Ridley MJ; Ridley DS; De Beer FC; Pepys MB
Clin Exp Immunol; 1984 Jun; 56(3):545-52. PubMed ID: 6378453
[TBL] [Abstract][Full Text] [Related]
44. Challenges presented by nerve damage in leprosy.
Harboe M; Aseffa A; Leekassa R
Lepr Rev; 2005 Mar; 76(1):5-13. PubMed ID: 15881032
[TBL] [Abstract][Full Text] [Related]
45. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
46. In vitro studies on extracellular matrix production by M.leprae infected murine neurofibroblasts.
Singh N; Birdi TJ; Chandrashekar S; Antia NH
Lepr Rev; 1998 Sep; 69(3):246-56. PubMed ID: 9805880
[TBL] [Abstract][Full Text] [Related]
47. Quantitative analysis of the sequence of nerve damage in experimental leprosy.
Bhat KR; Vaidya MC
Lepr India; 1982 Oct; 54(4):613-22. PubMed ID: 6763964
[No Abstract] [Full Text] [Related]
48. [Peripheral nerve damage in patients with leprosy].
Grimaud J
Rev Neurol (Paris); 2012 Dec; 168(12):967-74. PubMed ID: 23107882
[TBL] [Abstract][Full Text] [Related]
49. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA
J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278
[TBL] [Abstract][Full Text] [Related]
50. [Animal transmission of mycobacterium leprae--experimental leprosy].
Kohaska K
Nihon Rai Gakkai Zasshi; 1990; 59(2):86-97. PubMed ID: 2133036
[No Abstract] [Full Text] [Related]
51. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH
Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740
[TBL] [Abstract][Full Text] [Related]
52. Utility of beige mouse in leprosy research.
Gangadharam PR; Dhople AM
Indian J Lepr; 1992; 64(4):475-81. PubMed ID: 1308522
[TBL] [Abstract][Full Text] [Related]
53. Leprosy piRnome: exploring new possibilities for an old disease.
Pinto P; da Silva MB; Moreira FC; Bouth RC; Gobbo AR; Sandoval TV; Ribeiro-Dos-Santos AM; Vidal AF; Barreto JG; Santos S; Spencer JS; Salgado CG; Ribeiro-Dos-Santos Â
Sci Rep; 2020 Jul; 10(1):12648. PubMed ID: 32724108
[TBL] [Abstract][Full Text] [Related]
54. Genetic control of murine T cell proliferative responses to Mycobacterium leprae. V. Evidence for cross-reactivity between host antigens and Mycobacterium leprae.
Harris DP; Jones AG; Wade S; Krahenbuhl JL; Gillis TP; Watson JD
J Immunol; 1988 Sep; 141(5):1695-700. PubMed ID: 2970509
[TBL] [Abstract][Full Text] [Related]
55. Mycobacterium leprae-specific T cells from a tuberculoid leprosy patient suppress HLA-DR3-restricted T cell responses to an immunodominant epitope on 65-kDa hsp of mycobacteria.
Haanen JB; Ottenhoff TH; Lai A Fat RF; Soebono H; Spits H; de Vries RR
J Immunol; 1990 Dec; 145(11):3898-904. PubMed ID: 1701000
[TBL] [Abstract][Full Text] [Related]
56. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
57. Analysis of the leprosy agents Mycobacterium leprae and Mycobacterium lepromatosis in four countries.
Han XY; Aung FM; Choon SE; Werner B
Am J Clin Pathol; 2014 Oct; 142(4):524-32. PubMed ID: 25239420
[TBL] [Abstract][Full Text] [Related]
58. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
Levy L; Ji B
Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
[TBL] [Abstract][Full Text] [Related]
59. Immunity to leprosy. 1. The proliferative response of murine T lymphocytes to Mycobacterium leprae.
Douglas-Jones AG; Watson JD
Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):412-20. PubMed ID: 3900249
[TBL] [Abstract][Full Text] [Related]
60. Cytokine responses to Mycobacterium leprae unique proteins differentiate between Mycobacterium leprae infected and naive armadillos.
Pena M; Geluk A; Van Der Ploeg-Van Schip JJ; Franken KL; Sharma R; Truman R
Lepr Rev; 2011 Dec; 82(4):422-31. PubMed ID: 22439281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
